University of California, Irvine
- Advisory Board: Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; NextWave Pharmaceuticals
- Consultant: McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; National Institutes of Health; NextWave Pharmaceuticals; Noven Pharmaceuticals, Inc.; NuTec; Shire Pharmaceuticals Inc.; Taisho Pharmaceutical Co., Ltd.
- Grant Support: National Institute of Child Health and Human Development
- Research Support: Addrenex; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; NextWave Pharmaceuticals; Noven Pharmaceuticals, Inc.; Otsuka America Pharmaceuticals, Inc.; Psychogenics; Quintiles; Rhodes Pharmaceuticals; Shionogi Pharma, Inc.; Shire Pharmaceuticals Inc.
- Speakers Bureau: Noven Pharmaceuticals, Inc.; Shionogi Pharma, Inc.; Shire Pharmaceuticals Inc.
- Travel Support for participation in another meeting: Eli Lilly and Company; NextWave Pharmaceuticals